{"count": 2, "results": [{"_id": "33517287", "pmid": 33517287, "title": "Metformin Associates With Aggressive Features of Endometrial Cancer in Women With Type 2 Diabetes.", "journal": "Anticancer Res", "authors": ["Urpilainen E", "Arima R", "Karihtala P", "Puistola U", "Ahtikoski A"], "date": "2021-02-01T00:00:00Z", "doi": "10.21873/anticanres.14834", "meta_date_publication": "2021 Feb", "meta_volume": "41", "meta_issue": "2", "meta_pages": "821-828", "score": 50248.695, "text_hl": "Intriguingly, type 2 histology, deep myometrial invasion and the presence of @<m>DISEASE_Neoplasm_Invasiveness</m> @DISEASE_MESH:D009361 @@@lymphovascular invasion@@@ were more common in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ user group. ", "citations": {"NLM": "Urpilainen E, Arima R, Karihtala P, Puistola U, Ahtikoski A. Metformin Associates With Aggressive Features of Endometrial Cancer in Women With Type 2 Diabetes. Anticancer Res. 2021 Feb;41(2):821-828. PMID: 33517287", "BibTeX": "@article{33517287, title={Metformin Associates With Aggressive Features of Endometrial Cancer in Women With Type 2 Diabetes.}, author={Urpilainen E and Arima R and Karihtala P and Puistola U and Ahtikoski A}, journal={Anticancer Res}, volume={41}, number={2}, pages={821-828}}"}}, {"_id": "26245871", "pmid": 26245871, "pmcid": "PMC4553001", "title": "Metformin can block precancerous progression to invasive tumors of bladder through inhibiting STAT3-mediated signaling pathways", "journal": "J Exp Clin Cancer Res", "authors": ["Pan Q", "Yang GL", "Yang JH", "Lin SL", "Liu N", "Liu SS", "Liu MY", "Zhang LH", "Huang YR", "Shen RL", "Liu Q", "Gao JX", "Bo JJ"], "date": "2015-08-07T00:00:00Z", "doi": "10.1186/s13046-015-0183-0", "meta_date_publication": "2015 Aug 7", "meta_volume": "34", "meta_issue": "1", "meta_pages": "77", "score": 50049.082, "text_hl": "These findings provide for the first time the evidence that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can block @DISEASE_Precancerous_Conditions @DISEASE_MESH:D011230 @@@precancerous lesions@@@ progressing to @<m>DISEASE_Neoplasm_Invasiveness</m> @DISEASE_MESH:D009361 @@@invasive tumors@@@ through inhibiting the activation of @GENE_STAT3 @GENE_6774 @@@STAT3@@@ pathway, and may be used for treatment of the non-invasive @DISEASE_Urinary_Bladder_Neoplasms @DISEASE_MESH:D001749 @@@bladder cancers@@@ to prevent them from progression to @<m>DISEASE_Neoplasm_Invasiveness</m> @DISEASE_MESH:D009361 @@@invasive tumors@@@.", "citations": {"NLM": "Pan Q, Yang GL, Yang JH, Lin SL, Liu N, Liu SS, Liu MY, Zhang LH, Huang YR, Shen RL, Liu Q, Gao JX, Bo JJ. Metformin can block precancerous progression to invasive tumors of bladder through inhibiting STAT3-mediated signaling pathways J Exp Clin Cancer Res. 2015 Aug 7;34(1):77. PMID: 26245871", "BibTeX": "@article{26245871, title={Metformin can block precancerous progression to invasive tumors of bladder through inhibiting STAT3-mediated signaling pathways}, author={Pan Q and Yang GL and Yang JH and Lin SL and Liu N and Liu SS and Liu MY and Zhang LH and Huang YR and Shen RL and Liu Q and Gao JX and Bo JJ}, journal={J Exp Clin Cancer Res}, volume={34}, number={1}, pages={77}}"}}]}